Cheek filler face-off: new contender matches market leader

NCT ID NCT07162610

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a new dermal filler (Rejuviel V with lidocaine) works as well as an existing one (JUVEDERM VOLUMA with lidocaine) for temporarily adding volume to the mid-face area, including the cheeks. 89 Korean adults with moderate to severe volume loss received injections in both sides of the face. The goal was to see if the new filler is non-inferior in improving cheek fullness at 24 weeks, while also checking safety. Both fillers are designed to be temporary and do not cure any disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MID FACE VOLUME DEFICIT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Chung-Ang University Hospital

    Soeul, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.